{"entity":{"type":"insider","cik":"0001585697","url":"/insider/0001585697","json_url":"/insider/0001585697.json","name":"Hineline Lawrence J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":81,"n_filings":31,"first":"2014-09-10","last":"2024-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Hineline Lawrence J.","source":"filing","n_filings":31,"first_seen":"2014-09-10","last_seen":"2024-03-11"}],"transactions":[{"id":2675521,"accession":"0000950170-24-029582","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-24-029582","line_url":"/filing/0000950170-24-029582","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance, CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10121.0,"shares_display":"10,121","price_per_share":65.96058195830452,"price_display":"65.96","price_state":"stated","total_value":667587.05,"total_display":"667,587.05","total_whole":"667,587","shares_owned_after":64.0,"shares_owned_after_display":"64","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-11","scope":"insider","n_lines":5},{"id":2675496,"accession":"0000950170-24-029582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-029582","line_url":"/filing/0000950170-24-029582","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance, CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13132.0,"shares_display":"13,132","price_per_share":66.59765306122449,"price_display":"66.60","price_state":"stated","total_value":874560.38,"total_display":"874,560.38","total_whole":"874,560","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider","n_lines":2},{"id":2036947,"accession":"0000950170-24-021569","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-021569","line_url":"/filing/0000950170-24-021569","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance, CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13337.0,"shares_display":"13,337","price_per_share":69.42799730074229,"price_display":"69.43","price_state":"stated","total_value":925961.2,"total_display":"925,961.20","total_whole":"925,961","shares_owned_after":288.0,"shares_owned_after_display":"288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider","n_lines":5},{"id":2203318,"accession":"0000950170-24-011392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011392","line_url":"/filing/0000950170-24-011392","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance, CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance, CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11183.0,"shares_display":"11,183","price_per_share":66.62224179558258,"price_display":"66.62","price_state":"stated","total_value":745036.53,"total_display":"745,036.53","total_whole":"745,037","shares_owned_after":185.0,"shares_owned_after_display":"185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider","n_lines":2},{"id":8022795,"accession":"0001209191-23-037968","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-037968","line_url":"/filing/0001209191-23-037968","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81854.0,"shares_display":"81,854","price_per_share":63.97157524372663,"price_display":"63.97","price_state":"stated","total_value":5236329.32,"total_display":"5,236,329.32","total_whole":"5,236,329","shares_owned_after":3592.0,"shares_owned_after_display":"3,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-16","scope":"insider","n_lines":3},{"id":7810557,"accession":"0001209191-23-018284","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-018284","line_url":"/filing/0001209191-23-018284","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5582.0,"shares_display":"5,582","price_per_share":44.93163740594769,"price_display":"44.93","price_state":"stated","total_value":250808.4,"total_display":"250,808.40","total_whole":"250,808","shares_owned_after":258.0,"shares_owned_after_display":"258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-13","scope":"insider","n_lines":2},{"id":7810552,"accession":"0001209191-23-018284","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-018284","line_url":"/filing/0001209191-23-018284","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15663.0,"shares_display":"15,663","price_per_share":43.057952499521164,"price_display":"43.06","price_state":"stated","total_value":674416.71,"total_display":"674,416.71","total_whole":"674,417","shares_owned_after":2700.0,"shares_owned_after_display":"2,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider","n_lines":2},{"id":8105746,"accession":"0001209191-23-013436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013436","line_url":"/filing/0001209191-23-013436#line-2","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7455.0,"shares_display":"7,455","price_per_share":47.03,"price_display":"47.03","price_state":"stated","total_value":350608.65,"total_display":"350,608.65","total_whole":"350,609","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8743834,"accession":"0001209191-23-011994","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-23-011994","line_url":"/filing/0001209191-23-011994","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10443.0,"shares_display":"10,443","price_per_share":46.815173800632,"price_display":"46.82","price_state":"stated","total_value":488890.86,"total_display":"488,890.86","total_whole":"488,891","shares_owned_after":1794.0,"shares_owned_after_display":"1,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider","n_lines":4},{"id":8743820,"accession":"0001209191-23-011994","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-011994","line_url":"/filing/0001209191-23-011994","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53968.0,"shares_display":"53,968","price_per_share":49.83441113252297,"price_display":"49.83","price_state":"stated","total_value":2689463.5,"total_display":"2,689,463.50","total_whole":"2,689,464","shares_owned_after":1689.0,"shares_owned_after_display":"1,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-22","scope":"insider","n_lines":2},{"id":6399121,"accession":"0001209191-22-051194","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-051194","line_url":"/filing/0001209191-22-051194","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65164.0,"shares_display":"65,164","price_per_share":45.629578448222944,"price_display":"45.63","price_state":"stated","total_value":2973405.85,"total_display":"2,973,405.85","total_whole":"2,973,406","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider","n_lines":2},{"id":6606951,"accession":"0001209191-22-013352","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-013352","line_url":"/filing/0001209191-22-013352","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7454.0,"shares_display":"7,454","price_per_share":51.96526697075396,"price_display":"51.97","price_state":"stated","total_value":387349.1,"total_display":"387,349.10","total_whole":"387,349","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-25","scope":"insider","n_lines":3},{"id":6326289,"accession":"0001209191-22-012388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-012388","line_url":"/filing/0001209191-22-012388","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10443.0,"shares_display":"10,443","price_per_share":55.39655750263334,"price_display":"55.40","price_state":"stated","total_value":578506.25,"total_display":"578,506.25","total_whole":"578,506","shares_owned_after":4627.0,"shares_owned_after_display":"4,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider","n_lines":2},{"id":6843806,"accession":"0001209191-22-002987","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-002987","line_url":"/filing/0001209191-22-002987","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19639.0,"shares_display":"19,639","price_per_share":40.75666938235145,"price_display":"40.76","price_state":"stated","total_value":800420.23,"total_display":"800,420.23","total_whole":"800,420","shares_owned_after":4100.0,"shares_owned_after_display":"4,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider","n_lines":3},{"id":5262362,"accession":"0001209191-21-071174","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-071174","line_url":"/filing/0001209191-21-071174","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":47.5923652,"price_display":"47.59","price_state":"stated","total_value":8328663.91,"total_display":"8,328,663.91","total_whole":"8,328,664","shares_owned_after":48735.0,"shares_owned_after_display":"48,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-23","scope":"insider","n_lines":6},{"id":5394390,"accession":"0001209191-21-012955","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-012955","line_url":"/filing/0001209191-21-012955","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10442.0,"shares_display":"10,442","price_per_share":39.22862861520782,"price_display":"39.23","price_state":"stated","total_value":409625.34,"total_display":"409,625.34","total_whole":"409,625","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-22","scope":"insider","n_lines":2},{"id":5512943,"accession":"0001209191-21-003318","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-003318","line_url":"/filing/0001209191-21-003318","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19638.0,"shares_display":"19,638","price_per_share":32.01797433547205,"price_display":"32.02","price_state":"stated","total_value":628768.98,"total_display":"628,768.98","total_whole":"628,769","shares_owned_after":2376.0,"shares_owned_after_display":"2,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider","n_lines":2},{"id":5465131,"accession":"0001209191-21-001537","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-001537","line_url":"/filing/0001209191-21-001537","is_derivative":false,"issuer_cik":"0001567514","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001567514","owner_cik":"0001585697","owner_name":"Hineline Lawrence J.","owner_display_name":"Hineline Lawrence J.","owner_url":"/insider/0001585697","role":"Officer (SVP of Finance CFO)","role_mark":"O","role_mark_label":"Officer (SVP of Finance CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Finance CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15810.0,"shares_display":"15,810","price_per_share":31.309803921568626,"price_display":"31.31","price_state":"stated","total_value":495008.0,"total_display":"495,008.00","total_whole":"495,008","shares_owned_after":3450.0,"shares_owned_after_display":"3,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2021-01-04|5465126","ledger_fault":false,"count":{"value":81,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":81,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":81},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001567514","name":"Intra-Cellular Therapies, Inc.","url":"/issuer/0001567514","role":"Officer (SVP of Finance, CFO)","n_filings":31,"first_seen":"2014-09-10","last_seen":"2024-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585697","retrieved_at":"2026-08-22T12:33:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}